Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107869553 | 10786955 | 3 | F | 20150120 | 20150617 | 20150211 | 20150819 | PER | US-GILEAD-2015-0136785 | GILEAD | 74.00 | YR | E | F | Y | 0.00000 | 20150819 | N | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107869553 | 10786955 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | D | 1404528A | 22081 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107869553 | 10786955 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107869553 | 10786955 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107869553 | 10786955 | Drug ineffective | |
| 107869553 | 10786955 | Fatigue | |
| 107869553 | 10786955 | Joint swelling | |
| 107869553 | 10786955 | Nasal congestion | |
| 107869553 | 10786955 | Nasopharyngitis | |
| 107869553 | 10786955 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107869553 | 10786955 | 1 | 20150120 | 0 |